Steve HughesCMO at Avidity BiosciencesSpeaker
Agenda Sessions
KEYNOTE PANEL: Bridging the Gap: Addressing Regulatory Challenges in Oligonucleotide Development
, 9:10amView SessionAntibody Oligonucleotide Conjugates (Del-brax) positive clinical journey targeting Facioscapulohumeral Muscular Dystrophy
, 11:30amView Session